Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Respiratory
Sort By
Newest First
1 / 1
1 / 1
Intranasal Vaccines
Increasing Safety, Efficacy, and Global Equity with Intranasal Vaccines
Chad Costley, M.D.
BlueWillow Biologics
PAO-04-022-CL-15
Apr 28, 2022
Critical Care
Bringing Novel Solutions to Market for Unmet Needs
David Alvaro, Ph.D.; Leonard Mazur
Pharma's Almanac
PAO-04-022-CL-06
Apr 25, 2022
Respiratory Diseases
Developing a Novel Anti-Inflammatory for Patients with Severe Asthma
Robert Clarke, Ph.D
Kinaset Therapeutics
PAO-02-022-CL-13
Mar 12, 2022
Long COVID
Modernizing Respiratory Care with a Focus on Long COVID
VIDA Diagnostics
PAO-02-22-R250-23
Feb 28, 2022
Decentralized Clinical Trials
A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research
Tim Rich; Wesley Hicks, M.B.B.S., M.R.C.P., M.F.P.M.; Jenna McDonnell
PPD, part of Thermo Fisher Scientific
PAO-10-21-CL-04
Oct 12, 2021
Drug Development
HPV Treatment May Also Fight Rare Respiratory Disease
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-009
Apr 10, 2019
Respiratory
Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
Theravance Biopharma
PR-M11-18-NI-102
Nov 29, 2018
Respiratory
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx™ for Chronic Bronchitis in the United States
Gala Therapeutics
PR-M11-18-NI-023
Nov 07, 2018
New Facility
GSK Opens New Facility in Scotland
Emilie Branch
Pharma's Almanac
PAO-M11-18-NI-007
Nov 05, 2018
EU Approves AstraZeneca’s Respiratory Biologic
Nigel Walker
Nice Insight
PAO-M01-18-NI-031
Jan 18, 2018